| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/07/1994 | US5319139 Naphthalene derivatives |
| 06/07/1994 | US5319096 Neuroprotective agent |
| 06/07/1994 | US5318994 N-[2-(7-lower-alkoxynaphth-1-yl)ethyl]benzamides |
| 06/07/1994 | US5318985 Potentiation of NMDA antagonists |
| 06/07/1994 | US5318981 Unnatural dipeptoids of alpha-substituted tyrosine-phenylalanine derivatives |
| 06/07/1994 | US5318977 Antagonists of serotonin 5-HT3 receptors; gastrointestinal disorders; anxiolytic agents; antidepressants |
| 06/07/1994 | US5318969 Hypotensive, vasodilating action and muscle relaxants |
| 06/07/1994 | US5318967 2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole derivatives |
| 06/07/1994 | US5318966 Administering the enzyme inhibitor for treating alzheimer's disease, learning enhancement, brain disorders |
| 06/07/1994 | CA1330087C 1,4-disubstituted-piperidinyl compounds |
| 06/07/1994 | CA1330086C 1,4-disubstituted-piperidinyl compounds |
| 06/07/1994 | CA1330041C Hydrophylic matrix salbutamol tablet and method for preparing such |
| 06/01/1994 | EP0599697A1 Pyrrole derivatives, their preparation and application in therapy |
| 06/01/1994 | EP0599576A1 Schizophrenia |
| 06/01/1994 | EP0599240A1 Indole-7-carboxamide derivatives as analgesics |
| 06/01/1994 | EP0598765A1 Novel 2-amino naphthyridine derivative, its preparation and use. |
| 06/01/1994 | EP0502885B1 Imidazoquinoxaline compounds, their preparation and use |
| 06/01/1994 | EP0328535B1 The administration of monoamine acridines in cholinergic neuronal deficit states |
| 06/01/1994 | CN1087341A N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 06/01/1994 | CN1087340A Piperidine derivative, preparation of same and use of same in treatment |
| 06/01/1994 | CN1087262A Controlied release oxycodone compositions |
| 06/01/1994 | CN1024798C Basic-substituted 5-halo-thienoisothiazol-3(2H)-one 1,1-dioxides, a process for preparation thereof, and pharmaceutical preparations containing these compounds |
| 05/31/1994 | US5317101 Tricyclic heterocycles |
| 05/31/1994 | US5317025 Piperidinylthioindole derivatives, their methods of preparation and pharmaceutical compositions in which they are present, useful especially as analgesics |
| 05/31/1994 | US5317023 2-Phenyl-(imidazo(4,5-b)pyridyl-methyl-) derivatives; hypertensive agents; cognition activators |
| 05/31/1994 | US5317022 Pharmaceutical composition and use |
| 05/31/1994 | US5317021 Analgesics, anticonvulsants |
| 05/31/1994 | US5317020 Aromatic amine compounds their method of preparation and pharmaceutical compositions in which they are present |
| 05/31/1994 | US5317018 Antiepileptic agents |
| 05/31/1994 | US5317014 Peptides and pseudopeptides derived from tachykinin |
| 05/31/1994 | CA2110251A1 Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis |
| 05/31/1994 | CA1329937C 1-phenyl-3-naphthalenyloxypropanamines |
| 05/31/1994 | CA1329935C Imide derivatives, and their production and use |
| 05/27/1994 | CA2109777A1 Schizophrenia |
| 05/26/1994 | WO1994011501A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM |
| 05/26/1994 | WO1994011500A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/26/1994 | WO1994011394A2 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 05/26/1994 | WO1994011368A1 Quinuclidine derivative as substance p antagonist |
| 05/26/1994 | WO1994011360A1 1,4-benzothiazepines useful as neurological agents |
| 05/26/1994 | WO1994011347A1 Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists |
| 05/26/1994 | WO1994011346A1 Aza spiro alkanes derivatives as therapeutic agents |
| 05/26/1994 | WO1994011342A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
| 05/26/1994 | WO1994011337A1 Novel 3,3-diphenylpropylamines, their use and preparation |
| 05/26/1994 | WO1994011332A1 A novel arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent |
| 05/26/1994 | WO1994011021A1 Bradykinin antagonists |
| 05/26/1994 | WO1994011018A1 Opioid peptides |
| 05/26/1994 | WO1994011014A1 Compounds that inhibit t cell proliferation and methods using the same |
| 05/26/1994 | WO1994010999A1 Transdermal therapeutic system for administering physostigmin through the skin, and a method of producing the system |
| 05/26/1994 | WO1994009134A3 Modified ciliary neurotrophic factors |
| 05/26/1994 | DE4240672A1 Neues Verfahren zur Herstellung von beta-Carbolinen New process for the preparation of beta-carbolines |
| 05/26/1994 | DE4238223C1 Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung Transdermal therapeutic system for the administration of physostigmine to the skin, and process for its preparation |
| 05/26/1994 | CA2149056A1 Novel polypeptides with opioid receptor activity, nucleic acids encoding these substances and uses thereof |
| 05/26/1994 | CA2148584A1 Therapeutic agents |
| 05/26/1994 | CA2148582A1 Therapeutic agents |
| 05/26/1994 | CA2147869A1 Bradykinin antagonists |
| 05/26/1994 | CA2136077A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
| 05/26/1994 | CA2126697A1 Opioid peptides |
| 05/25/1994 | EP0597966A1 Cns active tetrahydrobenzothienopyridines |
| 05/25/1994 | EP0597956A1 Quinazoline derivatives as acetylcholinesterase inhibitors |
| 05/25/1994 | EP0249629B1 Methods and materials for alleviation of pain symptoms of malignant neoplasia |
| 05/25/1994 | CN1087083A Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives |
| 05/25/1994 | CN1024667C Process for preparing substituted aminomethytetralins and their heterocyclic analogues |
| 05/25/1994 | CN1024665C Ring-substituted 2-amino-1,2,3-tetrahydronaphthalenes and its producing process |
| 05/25/1994 | CN1024626C Process for preparing tetrahydrobenz |c,d¨ indole serotonin agonists |
| 05/25/1994 | CA2109774A1 Pyrrole derivatives, preparation and therapeutical use thereof |
| 05/24/1994 | US5314907 3-aminochroan compounds |
| 05/24/1994 | US5314906 Derivatives of physostigmine, their use and pharmaceutical formulations containing them |
| 05/24/1994 | US5314903 Benzimidazole compounds useful as calcium channel blockers |
| 05/24/1994 | US5314901 1,2,5,6-tetrahydropyridine oxime compounds |
| 05/24/1994 | US5314899 Epibatidine and derivatives, compositions and methods of treating pain |
| 05/24/1994 | US5314896 Dopaminergic agents, antipsychotic and hypotensive agents |
| 05/24/1994 | US5314889 Hormone antagonists |
| 05/24/1994 | US5314885 Psychological disorders, anticonvulsants |
| 05/24/1994 | US5314884 2-pyrimidinyl-1-piperazine derivatives processes for their preparation and medicaments containing them |
| 05/24/1994 | CA1329772C Use of 2-amino-4-morpholino-6-propyl-1,3,5-triazine for the preparation of medicaments for the treatment of cognitive and behavioral disorders associated with aging and with dementia syndromes |
| 05/19/1994 | DE4300697C1 New 2-pyrrolidino-ethyl ester of ketorolac - useful as analgesic, antiinflammatory and antipyretic agent with low ulcerogenicity |
| 05/18/1994 | EP0597088A1 Novel imidazole derivatives, their preparation and therapeutic applications |
| 05/18/1994 | EP0597071A1 Androgens for stimulating the central nervous system and for treating osteoporosis |
| 05/18/1994 | EP0596937A1 Plasmalopsychosines and plasmalocerebrosides and methods of treating neuronal diseases employing the same |
| 05/18/1994 | EP0596933A1 5-ht4 receptor antagonists |
| 05/18/1994 | EP0596897A1 Hydroisoquinoline derivatives |
| 05/18/1994 | EP0596891A1 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles, their preparation and their use |
| 05/18/1994 | CN1086824A Calcium channel blocking polypeptide from agelenopsis aperta |
| 05/18/1994 | CN1086818A Asymmetrically substituted xanthines |
| 05/18/1994 | CN1086811A Novel nicotincacid esters |
| 05/18/1994 | CN1086710A Henbane drug give-up agent and its preparation and use |
| 05/18/1994 | CN1086708A Memanting-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 05/18/1994 | CN1024552C Process for pyridoindole derivatives |
| 05/18/1994 | CN1024547C Process for preparing cyclic amine compound |
| 05/17/1994 | US5312925 Neuroleptic agents |
| 05/17/1994 | US5312819 Schizophrenia |
| 05/17/1994 | US5312816 Method of combatting osteoporosis in mammalian subjects, utilizing organic boron compounds |
| 05/17/1994 | US5312809 Physiologically active substance derived from malt and process for the production thereof |
| 05/17/1994 | US5312629 Method for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases |
| 05/17/1994 | US5312625 Fused 7-membered cyclic compound and antipsychotic preparation containing the same |
| 05/17/1994 | CA1329617C Resolved amino pyrrolidine neuroprotective agents |
| 05/17/1994 | CA1329605C Antidepressant n-substituted nicotinamide compounds |
| 05/17/1994 | CA1329594C 5-(substituted)amino)-8-(phenyl or substituted phenyl)-3h,6h-1,4,5a,8a-tetraazaacenaphthyen-3-ones |
| 05/11/1994 | WO1994010569A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE |
| 05/11/1994 | WO1994010196A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |